Back

Left atrioventricular ratio as a metric to contextualise physiological cardiac remodelling

3 April 2025 (11:30 - 12:15)
Organised by: Logo
Congress Presentation Part of: Physiologic or pathologic: what test results mean in athletes Imaging of Cardiac Morphology, Dimensions, Volume and Mass EAPC Premium Access ESC Preventive Cardiology 2025 European Association of Preventive Cardiology (EAPC)

About the speaker

Photo
Mr Luke Spencer

St. Vincent's Institute of Medical Research, Melbourne (Australia)

6 More presentations in this session

Presentation thumbnail
Arrhythmic prevalence during Harvard Step Test and Maximal Exercise Test in young athletes: a comparative analysis
Doctor F. Sollazzo (Rome, IT)
Abstract Slides
Presentation thumbnail
Reproducibility of exercise-induced ventricular arrhythmias in competitive athletes: holter monitoring vs exercise test
Doctor G. Ragazzoni (Siena, IT)
Abstract Slides
Presentation thumbnail
Influence of workload-indexed blood pressure response to exercise on clinical and echocardiographic parameters in elite athletes
Doctor G. Di Gioia (Rome, IT)
Abstract Slides
Presentation thumbnail
Markers of atrial myopathy in endurance athletes
Mr L. Spencer (Melbourne, AU)
Abstract Slides
Presentation thumbnail
QRS voltages in the limb leads - findings from a nationwide cardiac screening program in adolescent athletes and non-athletes (BEAT-IT)
Doctor D. Cuschieri (Msida, MT)
Abstract Slides

Access the full session

Session thumbnail
Physiologic or pathologic: what test results mean in athletes

The Event

Event poster

ESC Preventive Cardiology 2025

3 April 2025 11:30 CET
You may be interested in
thumbnail
Congress Presentation
Left atrial function and left atrioventricular coupling indices for atrial fibrillation prediction in hypertrophic cardiomyopathy
thumbnail
Congress Presentation
Impact of left atrial size on outcomes in patients with atrial functional mitral regurgitation
thumbnail
Congress Presentation
Clinical utility of left atrioventricular coupling index to define the response to cardiac resynchronization therapy in heart failure patients

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources